Richmond Pharmacology is excited to join the 11th Annual Outsourcing in Clinical Trials Korea 2026 in Seoul, South Korea, on 1–2 December 2026.

As a key regional meeting for clinical operations, outsourcing strategy, and partnership development, OCT Korea brings together leading sponsors, CROs, researchers, and innovative solution providers to explore best practices and real‑world insights shaping the future of clinical trials in Korea and the broader Asia‑Pacific region.

Representing Richmond Pharmacology

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Clinical operations strategy and trial optimisation in Asia‑Pacific
  • CRO partnerships, outsourcing models, and vendor management
  • Regulatory developments and study‑start‑up pathways in Korea
  • Patient recruitment approaches and site engagement practices
  • Innovations enhancing quality, efficiency, and trial delivery

Connect With Us

If you are attending OCT Korea 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: 11th Annual Outsourcing in Clinical Trials Korea 2026 - Arena International

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event